Afghanistan vs Kazakhstan: Average non-HDL cholesterol levels
Afghanistan
3.1
in 2018
Kazakhstan
3.1
in 2018
Afghanistan rank
134th
Kazakhstan rank
134th
Average non-HDL cholesterol levels over time
- Afghanistan
- Kazakhstan
How they compare
Afghanistan currently reports 3.1 against 3.1 in Kazakhstan, a difference of 0.
Across all 39 years both countries report, Kazakhstan has been ahead every year.
Afghanistan ranks 134th and Kazakhstan ranks 134th of 191 countries.
Kazakhstan has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Afghanistan | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.98 | 3.3 | 0.32 | Kazakhstan |
| 1990s | 3.1 | 3.25 | 0.15 | Kazakhstan |
| 2000s | 3.1 | 3.17 | 0.07 | Kazakhstan |
| 2010s | 3.1 | 3.1 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Afghanistan or Kazakhstan?
- Afghanistan, at 3.1 against 3.1 in Kazakhstan as of 2018.
- What is the difference in average non-hdl cholesterol levels between Afghanistan and Kazakhstan?
- 0, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Kazakhstan?
- 39 years are reported by both, from 1980 to 2018.
- How do Afghanistan and Kazakhstan rank globally for average non-hdl cholesterol levels?
- Afghanistan ranks 134th and Kazakhstan ranks 134th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.